
Medtronic (NYSE:MDT) said today that it has launched the VenaSeal closure system in India for patients with chronic venous disease.
VenaSeal is used in a minimally invasive procedure that uses a proprietary medical adhesive to close the diseased veins. Using ultrasound, the physician guides a catheter through a small access site in the leg and into the diseased area of the vein. Once in place, the physician administers the VenaSeal adhesive in segments and with manual compression, closes the vein. Blood is re-routed through other healthy veins in the leg.
“VenaSeal is an innovative approach to vein closure and is designed to minimize patient discomfort and reduce recovery time,” said Madan Krishnan, VP & managing director of India Medtronic in a news release. “Thousands of patients around the world have benefited from this therapy and we are pleased to now offer this advanced technology in India.”